Medtronic Receives FDA Approval for First Pacemaker System in the U.S. Designed for Use in the MRI Environment

Medtronic, Inc. MDT today announced that the U.S. Food and Drug Administration (FDA) approved its Revo MRI SureScan pacing system, the first and only pacemaker in the U.S. specifically designed for use in an Magnetic Resonance Imaging environment and approved as MR-Conditional. Shipments of Revo MRI will begin immediately.